Modulators of cystic fibrosis transmembrane conductance regulator

Details for Australian Patent Application No. 2009308232 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Binch, Hayley; Fanning, Lev T.D.; Botfield, Martyn; Grootenhuis, Peter D.J.; Van Goor, Fredrick; Numa, Mehdi Michel Djamel

Agent Cullens

Pub. Number AU-A-2009308232

PCT Pub. Number WO2010/048564

Priority 61/107,844 23.10.08 US

Filing date 23 October 2009

Wipo publication date 29 April 2010

International Classifications

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/048564 Priority application(s): WO2010/048564

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009308236-Modified photosynthetic microorganisms for producing triglycerides

2009308217-5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom